MBOAT7 and metabolic dysfunction-associated steatotic liver disease: Hence, the assessment of ccf-mtDNA levels may mirror mitochondrial derangement due to TM6SF2 and MBOAT7 deletion, thus paving the way to consider them as a mitochondrial circulating biomarker of progressive MASLD in genetically predisposed individuals.